XML 50 R31.htm IDEA: XBRL DOCUMENT
v3.25.1

Accrued Expenses (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Payables and Accruals [Abstract] |
Schedule of Accrued Expenses | Accrued expenses consisted of the following at December 31: Schedule of Accrued Expenses
|  | 2024 |  |  | 2023 |
Clinical trial costs |  | $ | 16,708,499 |  |  | $ | 6,464,772 |
Accrued compensation |  |  | 3,987,786 |  |  |  | 1,763,316 |
Other |  |  | 1,384,803 |  |  |  | 641,512 |
Employee stock purchase plan |  |  | 103,860 |  |  |  | 57,494 |
Total |  | $ | 22,184,948 |  |  | $ | 8,927,094 |

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration